Clinical Impact of Change of FLT3 Mutation Status in Acute Myeloid Leukemia (AML) Patients

被引:0
|
作者
Warren, M.
Luthra, R.
Yin, C. C.
Ravandi, F.
Medeiros, L. J.
Zuo, Z.
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1588
引用
收藏
页码:379A / 379A
页数:1
相关论文
共 50 条
  • [1] Clinical Impact of Change of FLT3 Mutation Status in Acute Myeloid Leukemia (AML) Patients
    Warren, M.
    Luthra, R.
    Yin, C. C.
    Ravandi, F.
    Medeiros, L. J.
    Zuo, Z.
    MODERN PATHOLOGY, 2012, 25 : 379A - 379A
  • [2] Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients
    Warren, Mikako
    Luthra, Rajyalakshmi
    Yin, C. Cameron
    Ravandi, Farhad
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Medeiros, L. Jeffrey
    Zuo, Zhuang
    MODERN PATHOLOGY, 2012, 25 (10) : 1405 - 1412
  • [3] AML, acute myeloid leukemia, FLT3 gene mutation Specific Features of the FLT3+Acute Myeloid Leukemia Course
    Radzhabova, Asiyat M.
    Martynkevich, Irina S.
    Motyko, Ekaterina V.
    Polushkina, Lubov B.
    Bakay, Marina P.
    Kuzyaeva, Anastasiya A.
    Voloshin, Sergey V.
    Potihonova, Nadezhda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S228 - S229
  • [4] Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study
    Cuervo-Sierra, Jorge
    Carlos Jaime-Perez, Jose
    Martinez-Hernandez, Ramon A.
    Garcia-Sepulveda, Ricardo D.
    Sanchez-Cardenas, Monica
    Gomez-Almaguer, David
    Ortiz-Lopez, Rocio
    Villarreal-Villarreal, Cesar D.
    Ruiz-Arguelles, Guillermo J.
    Ruiz-Delgado, Guillermo
    Lutz-Presno, Julia
    Garces-Eisele, Javier
    Ignacio-Ibarra, Gregorio
    Mucino-Hernandez, Gabriel
    Arana-Trejo, Rosa M.
    Jimenez-Mejia, Angelica M.
    Vasquez-Palacio, Gonzalo
    ARCHIVES OF MEDICAL RESEARCH, 2016, 47 (03) : 172 - 179
  • [5] FLT3 Inhibitor Therapy for Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Impact On Survival According to FLT3 Status.
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Gautam, Borthakur
    Parikh, Sameer A.
    Konopleva, Marina
    Kornblau, Steven M.
    Andreeff, Michael
    O'Brien, Susan
    Cones, Jorge
    BLOOD, 2009, 114 (22) : 424 - 425
  • [6] Clinical significance of FLT3/ITD and NPM1 mutation in acute myeloid leukemia (AML).
    Suzuki, Rikio
    Onizuka, Makoto
    Shimada, Masako
    Iwaki, Yasunobu
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Hotta, Tomomitsu
    Ando, Kiyoshi
    BLOOD, 2006, 108 (11) : 188B - 188B
  • [7] Impact of monosomal karyotype and FLT3 status on post-transplant relapse in acute myeloid leukemia (AML).
    Jimenez, Antonio Martin
    De Lima, Marcos
    Popat, Uday R.
    Borthakur, Gautam
    Abruzzo, Lynne
    Andersson, Borje
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Chen, Julianne
    Bashir, Qaiser
    Ciurea, Stefan O.
    Kebriaei, Partow
    Ahmed, Sairah
    Khouri, Issa F.
    Kongtim, Piyanuch
    Qazilbash, Muzaffar H.
    Rondon, Gabriela
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Oran, Betul
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?
    Ma, Wanlong
    De Dios, Ivan
    Funari, Vincent
    Sudarsanam, Sucha
    Jiang, Shi-Ping
    Agersborg, Sally
    Hummel, Jennifer
    Blocker, Forrest
    Albitar, Maher
    BLOOD, 2017, 130
  • [9] Treatment of Acute Myeloid Leukemia with the FLT3 Gene Mutation
    Carlos Best-Aguilera
    O. Rodrigo Gómez-Vázquez
    A. Elizabeth Guzmán-Hernández
    R. Monserrat Rojas-Sotelo
    Current Oncology Reports, 2017, 19
  • [10] Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
    Song, Moo-Kon
    Park, Byeong-Bae
    Uhm, Ji-Eun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)